Understanding Dementia Care at the End of Life
Hours: 1.00
Dementia is the 5th leading cause of death in people over the age of 65 and despite literature focus on this disease state, no new medications have been developed that are indicated for disease state in over 10 years. With the increasing geriatric population, clinicians need to understand the benefits of discontinuing cognitive-based therapy at end of life and manage symptoms via non-pharmacological methods and medications other than antipsychotics.
Dementia is the 5th leading cause of death in people over the age of 65 and despite literature focus on this disease state, no new medications have been developed that are indicated for disease state in over 10 years. With the increasing geriatric population, clinicians need to understand the benefits of discontinuing cognitive-based therapy at end of life and manage symptoms via non-pharmacological methods and medications other than antipsychotics.
American Nurses Credentialing Center
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses will receive 1.00 Nursing Contact Hours after successfully completing this course.
South Carolina Board of Nursing
South Carolina Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
West Virginia Board of Registered Nursing
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
New Mexico Board of Nursing
New Mexico Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
District of Columbia Board of Nursing
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 1.00 contact hours for participating in this course.
Florida Board of Nursing
Florida Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Georgia Board of Nursing
Georgia Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Arkansas State Board of Nursing
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 1.00 contact hours for participating in this course.
Kentucky Board of Nursing
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Mississippi Board of Nursing
Mississippi Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
North Dakota Board of Nursing
North Dakota Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Describe dementia and its clinical presentation
Discuss hospice criteria for dementia
Review treatment options and discuss their use in hospice
Explore future treatment options for dementia
As Director of Clinical Education at Enclara Pharmacia, Marisa is responsible for the coordination, integration, maintenance and advancement of Enclara Pharmacia’s education support services. Prior roles held by Marisa include manager of the West Deptford clinical call center, clinical pharmacist and new hire pharmacist trainer. She has 15 years of experience as a pharmacist in various fields including 11 years of hospice pharmacy experience, as well as clinical roles in both the hospital and home infusion settings. Throughout Marisa’s career, she has been continuously involved in the education and training of healthcare professionals and students. Marisa earned her doctor of pharmacy degree at Wilkes University, Nesbitt School of Pharmacy. She completed a 1-year post-graduate pharmacy practice residency program and maintains certification as a Board Certified Pharmacotherapy Specialist (BCPS). Disclosure: Marisa Todd, PharmD, BCPS has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.
The target audience for this course is: Nurses; in the following settings: Hospice.
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.
